Amsterdam institute for Immunology and Infectious diseases
AI&I news
Vici Grant for Matthijs Brouwer: Faster, more Accurate, and Affordable Tests for Diagnosing Brain InfectionsWe are proud to announce that three Amsterdam UMC researchers, including two from AI&I, have each been awarded a prestigious €1.5 million Vici grant from the Dutch Research Council (NWO). This funding will enable them to develop innovative research lines and expand their teams over the next five years. In this article, we highlight the work of Prof. Matthijs Brouwer, who received the Vici grant for his groundbreaking research on improving the diagnosis of brain infections.
National INFECT-TT program invests 7 million in accelerated clinical product development for infectious diseasesIn May 2026, the national valorisation programme InFECT-TT, under the umbrella of the InFECT-NL, will officially launch, together with the Infectious Diseases Innovation Fund (IDIF). InFECT-NL supports the clinical development of vaccines and therapies against infectious diseases and strengthens the pandemic preparedness of the Netherlands.
ESCMID Global 2026: Advancing Infectious Diseases in a Changing WorldESCMID Global is the world’s premier congress for Clinical Microbiology and Infectious Diseases, bringing together over 16,000 international experts. This year, AI&I members were once again actively involved, contributing to discussions, presentations, and collaborations that shape the future of our field.
